Prescription drug prices just posted their biggest annual drop in sixty years.
Trump posted the numbers himself and linked straight to the outlet that tried handing his own win to Joe Biden.
The White House had one blunt word for that theory and it was not kind.
The Number Nobody Can Spin Away
Prescription drug prices fell 3.1 percent over the twelve months ending in July.
That is the sharpest annual decline recorded since 1963.
Medicinal drug prices overall dropped 2.7 percent, also a record.
The White House credits Trump's Most Favored Nation executive order, signed in May of last year.
Seventeen drugmakers control roughly 86 percent of the branded drug market, and every one of them just signed on to charge Americans no more than they charge patients in comparably wealthy countries.
Pfizer signed on.
So did Merck and Sanofi, three companies that spent decades charging Americans multiples of what they charged patients in Europe for the identical pill.
That is the deal Trump promised on the campaign trail and Washington insisted he could never actually close.
Trump Posted His Own Win and Linked the Outlet Trying to Steal It
Trump shared the record price drop himself on social media, and he linked directly to the Washington Post story reporting it.
The Post's own numbers proved his point.
Outlets scrambling to explain the drop reached for anything except the executive order sitting right in front of them.
Some pointed to more generic drugs entering the market.
Some pointed to discount GLP-1 weight loss drugs.
Plenty pointed straight at Biden's Inflation Reduction Act, a law that took effect years before this record-breaking drop showed up in the data.
White House spokesperson Kush Desai called the Biden credit-grab "idiotic and unfounded."
Desai added that the IRA's negotiated prices amounted to nothing patients were not already getting through their own insurers.
NewsBusters caught evening network newscasts ignoring the record price drop entirely for days, only for anchors to resurface the story once they found an angle that left Trump out of it.
The Same Reporters Who Called This Impossible Now Call It Biden's Idea
Border numbers improve and these same newsrooms suddenly credit "existing trends."
Drug prices post their sharpest drop in a generation and the byline suddenly belongs to a three-year-old law that never touched most patients' bills.
The pattern only runs one direction.
When something breaks under Trump, it is his fault within the hour.
When something improves under Trump, the same newsroom needs a week to find a different name to put on it.
Republicans Warned This Fight Would Get Ugly and It Did
Congress watched this fight closely because Most Favored Nation pricing threatened a business model pharmaceutical companies had protected for decades.
Lobbyists warned lawmakers that forcing American prices down to match Europe would gut innovation and kill new drug development.
None of that happened.
Drugmakers signed on anyway rather than risk losing access to American patients altogether.
Every one of those innovation warnings came from an industry that had spent decades setting its own prices with no one able to say no.
Why This Fight Is Not Over Yet
Some of these Most Favored Nation agreements only run for three years, meaning drugmakers agreed to hold the line through little more than a single presidential term.
That is not an accident.
Pharmaceutical companies are betting Washington's attention moves on long before those deals come up for renewal.
The same reporters scrambling to hand this win to a three-year-old law will have a much harder time explaining it away if Trump makes these prices permanent instead of temporary.
Sources:
- Bob Hoge, "Trump Celebrates Plummeting Prescription Drug Prices As the Media Feverishly Works to Credit Biden," RedState, August 17, 2026.
- "Savings From Most-Favored-Nation Drug Pricing Policy," The White House, May 2026.
- Joseph Vazquez, "Too Stoned From TDS: Evening Nets Ignore Drug Prices Recording Sharpest Drop in 60 Yrs," NewsBusters, August 14, 2026.
- Donald J. Trump, Truth Social post linking Washington Post drug price coverage, August 13, 2026.
- "Nine of the Largest Pharma Companies Ink Deals With Trump to Lower Drug Prices," CNBC, December 19, 2025.
